Literature DB >> 12139081

Assessing health-related quality of life in patients with migraine.

W J Becker.   

Abstract

BACKGROUND: The place of health-related quality of life (HRQoL) instruments in clinical research trials and clinical practice as compared to more traditional clinical outcome measures such as headache intensity and frequency is unclear.
OBJECTIVES: To review the current status of HRQoL measurement in migraine.
METHODS: A literature search was done for HRQoL and migraine. Selected articles dealing with migraine and commonly used HRQoL instruments and HRQoL measures used in recent clinical trials were reviewed.
RESULTS: Several general and migraine specific HRQoL instruments can detect changes over time in response to at least major changes in migraine therapy. Both also show a correlation with clinical headache features. However, their sensitivity to detect clinically significant changes over time is not clear.
CONCLUSION: The SF-36, a general HRQoL measure and several migraine-specific HRQoL instruments are useful endpoints for migraine clinical trials. Their role in clinical practice is yet to be established.

Entities:  

Mesh:

Year:  2002        PMID: 12139081     DOI: 10.1017/s031716710000189x

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  7 in total

1.  Manual Therapy and Quality of Life in People with Headache: Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Luca Falsiroli Maistrello; Marco Rafanelli; Andrea Turolla
Journal:  Curr Pain Headache Rep       Date:  2019-08-10

2.  Single-item electronic administration of the SF-36v2 Health Survey.

Authors:  Diane M Turner-Bowker; Renee N Saris-Baglama; Michael A Derosa
Journal:  Qual Life Res       Date:  2012-05-04       Impact factor: 4.147

3.  Health-related quality of life and ways of coping with stress in patients with migraine.

Authors:  Mirjana Vladetić; Davor Jančuljak; Silva Butković Soldo; Kristina Kralik; Krunoslav Buljan
Journal:  Neurol Sci       Date:  2016-11-12       Impact factor: 3.307

Review 4.  Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.

Authors:  Lihua Zhang; Joel W Hay
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Health-related quality of life and associated factors in Chinese menstrual migraine patients: a cross-sectional study.

Authors:  Wenxiu Luo; Xing Cao; Jiayu Zhao; Jiaming Yang; Yu Cen; Jinlong He; Jing Luo; Yunling Zhong; Ying Luo; Xinyue Wang; Liqiu Yang; Xingyu Feng; Xiaoqing Pang; Jiazhu Zhang; Jiaming Luo
Journal:  BMC Womens Health       Date:  2022-05-15       Impact factor: 2.742

6.  Effect of Atlas Vertebrae Realignment in Subjects with Migraine: An Observational Pilot Study.

Authors:  H Charles Woodfield; D Gordon Hasick; Werner J Becker; Marianne S Rose; James N Scott
Journal:  Biomed Res Int       Date:  2015-12-10       Impact factor: 3.411

7.  Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(-receptor) antibodies.

Authors:  Bianca Raffaelli; Uwe Reuter; Maria Terhart; Jasper Mecklenburg; Lars Neeb; Lucas Hendrik Overeem; Anke Siebert; Maureen Steinicke
Journal:  J Headache Pain       Date:  2021-12-31       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.